Müller-Löbnitz C mit Kommentar von Tackenberg B

2. Februar 2021
Fingolimod The oral alternative to interferon beta, highly efficient and safe in multiple sclerosis
J Med Drug Rev 2011;1;29-36 (Review-Artikel in deutscher Sprache) Fingolimod is a new significant option for oral treatment of multiple sclerosis. Its mode of action totally differs from all known standard therapies. Fingolimod binds to the sphingosine-1-phosphate-receptor on lymphocytes, blocks lymphocyte migration from lymph nodes and thus reduces the infiltration […]